Evolving Concepts in Dilated Cardiomyopathy
Эволюция представлений о дилатационной кардиомиопатии
2017-12-22
SCID: 54.1/7p3d3p7m
Discuss with AI
Arrhythmic risk stratificationCardiac magnetic resonanceDilated cardiomyopathyGenetic cardiomyopathySystolic heart failure
Figures from the paper
Abstract (AI)
Dilated cardiomyopathy (DCM) represents a particular aetiology of systolic heart failure that frequently has a genetic background and usually affects young patients with few co-morbidities. The prognosis of DCM has improved substantially during the last decades due to more accurate aetiological characterization, the red-flag integrated approach to the disease, early diagnosis through systematic familial screening, and the concept of DCM as a dynamic disease requiring constant optimization of medical and non-pharmacological evidence-based treatments. However, some important issues in clinical management remain unresolved, including the role of cardiac magnetic resonance for diagnosis and risk categorization and the interaction between genotype and clinical phenotype, and arrhythmic risk stratification. This review offers a comprehensive survey of these and other emerging issues in the clinical management of DCM, providing where possible practical recommendations.
Key Findings
1
DCM is increasingly understood as a dynamic disease requiring ongoing adjustment of medical and non-pharmacological treatments.
2
DCM prognosis has substantially improved through precise etiological characterization, integrated red-flag assessment, systematic familial screening, and continuously optimized evidence-based therapy.
3
Dilated cardiomyopathy is a form of systolic heart failure that frequently has a genetic basis and typically affects young patients with few comorbidities.
4
Important management questions remain unresolved regarding cardiac magnetic resonance for diagnosis and risk categorization, genotype–phenotype interactions, and arrhythmic-risk stratification.
5
The review surveys emerging clinical-management issues in DCM and provides practical recommendations where evidence permits.
Research Object
dilated cardiomyopathy (DCM)
Research Subject
clinical management, diagnosis, prognosis, and arrhythmic risk stratification of DCM, including genotype–phenotype interactions
Publication Details
Publication Date
2017-12-22
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest